Drug Type Small molecule drug |
Synonyms Clavulanic Acid/Cefdinir, FULLCEF PLUS |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Turkey (01 Nov 2017), |
Regulation- |
Molecular FormulaC8H9NO5 |
InChIKeyHZZVJAQRINQKSD-PBFISZAISA-N |
CAS Registry58001-44-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Tract Infections | Turkey | 01 Nov 2017 |